Form 8-K - Current report:
SEC Accession No. 0001564590-21-028069
Filing Date
2021-05-14
Accepted
2021-05-14 17:22:53
Documents
12
Period of Report
2021-05-12
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20210512.htm   iXBRL 8-K 32527
  Complete submission text file 0001564590-21-028069.txt   158068

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fgen-20210512.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20210512_lab.xml EX-101.LAB 18732
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20210512_pre.xml EX-101.PRE 11173
5 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20210512_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 21926132
SIC: 2834 Pharmaceutical Preparations